Lymphoplasmacytic lymphoma surgery: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) No edit summary |
Sara Mohsin (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Surgery]] is not the [[first-line treatment]] option for [[patients]] with [[lymphoplasmacytic lymphoma]]. [[Stem cell transplant]] is usually reserved for [[patients]] with either [[relapse]] or [[refractory]] [[lymphoplasmacytic lymphoma]]. | [[Surgery]] is not the [[first-line treatment]] option for [[patients]] with [[lymphoplasmacytic lymphoma]]. [[Stem cell transplant]] is usually reserved for [[patients]] with either [[relapse]] or [[refractory]] [[lymphoplasmacytic lymphoma]]. In very [[rare]] [[Case-based reasoning|cases]], laporotomy or laproscopy might be required. | ||
==Surgery== | ==Surgery== |
Revision as of 15:32, 15 August 2019
Lymphoplasmacytic lymphoma Microchapters |
Differentiating Lymphoplasmacytic Lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Lymphoplasmacytic lymphoma surgery On the Web |
American Roentgen Ray Society Images of Lymphoplasmacytic lymphoma surgery |
Risk calculators and risk factors for Lymphoplasmacytic lymphoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Overview
Surgery is not the first-line treatment option for patients with lymphoplasmacytic lymphoma. Stem cell transplant is usually reserved for patients with either relapse or refractory lymphoplasmacytic lymphoma. In very rare cases, laporotomy or laproscopy might be required.
Surgery
- Stem cell transplant is usually reserved for patients when either lymphoma comes back (recurs/relapses) after treatment or doesn’t respond to other treatments (called refractory disease).[1]
- Many people with lymphoplasmacytic lymphoma are older or may not be in good health, so a stem cell transplant may not be a good treatment option for them.
- In very rare cases, laporotomy or laproscopy might be required.
References
- ↑ Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015